Header | Pharma Connect
CQV & Compliance Readiness

Compliance readiness starts long before installation is complete.

CQV requirements are integrated from the design stage, helping systems move through specification, installation, testing and documentation with operational readiness in mind.
Our approach connects commissioning, qualification and validation activities across the project lifecycle, creating a clear pathway from approved requirements to demonstrated performance.

CQV and Compliance Readiness
CQV PLANNINGfrom design to verification
Compliance readiness, planned early
Clear requirements

User needs and acceptance criteria defined early.

Risk-based focus

CQV effort aligned with system criticality.

Traceable evidence

Records maintained throughout the lifecycle.

Compliance Readiness
The approach

One verification pathway from design to performance.

CQV planning begins by defining system boundaries, responsibilities, critical requirements and the evidence needed to demonstrate readiness.
Design reviews, installation checks, functional testing and performance verification are then connected through a controlled sequence. This helps maintain traceability between what was required, what was installed and how the system performs.

Acceptance criteria established earlyTesting expectations are defined before protocols reach execution.
Traceability maintained throughoutRequirements, tests, results and approved changes remain connected across each stage.
Core focus areas

Structured for compliant and operational readiness.

A coordinated CQV strategy brings planning, risk assessment, protocol execution and system verification into one controlled framework.

Commissioning & Validation Master Plans icon

CQV Master Planning

Structured planning that defines the CQV strategy, system boundaries, responsibilities, testing approach and execution pathway.

Cleaning Validation Master Plans icon

Cleaning Validation Master Plans

Cleaning-validation strategy developed around product-contact surfaces, cleaning processes, acceptance criteria and documentation requirements.

Process Validation icon

Process Validation

Planning and execution support to demonstrate that manufacturing processes can consistently deliver the intended quality outcome.

Risk-Based Strategies icon

Risk-Based Strategies

CQV activities shaped through risk-based thinking, with effort focused according to system criticality and potential quality impact.

Complete System Validation icon

System Qualification & Validation

Qualification and validation support across critical equipment, utilities, HVAC, automation, cleanrooms and process-related systems according to their intended use and GMP impact.

Protocol Development & Execution icon

Protocol Development & Execution

Preparation and execution support for qualification and validation protocols across key project stages.

Qualification pathway

Evidence developed through each verification stage.

The qualification pathway progresses from confirming the design basis to verifying installation, operation and performance under expected conditions.

Design Qualification - DQ

Design intent, specifications and system requirements reviewed for alignment with user needs and GMP expectations.

Installation Qualification - IQ

Systems and equipment verified against approved designs, specifications and manufacturer requirements.

Operational Qualification - OQ

Systems tested to confirm operation within defined ranges, functions and control parameters.

Performance Qualification - PQ

Equipment and systems verified for consistent performance under expected operating conditions.

Standards & guidance

Developed with recognised CQV and validation frameworks in mind.

CQV and validation activities are planned with reference to applicable regulatory expectations, project requirements, site quality systems and recognised industry guidance.

ASTM E2500-25science- and risk-based specification, design and verification of pharmaceutical and biopharmaceutical manufacturing systems
ICH Q9(R1)Quality risk-management principles supporting risk identification, assessment, control, communication and review.
EU GMP Annex 15Guidance for qualification and validation of facilities, utilities, equipment, processes and cleaning activities.
Applicable GMP expectationsGMP requirements considered according to the product, process, dosage form, project location and intended regulatory market.
Site quality requirementsSite-specific procedures, documentation practices, acceptance criteria and quality-approval requirements incorporated into the CQV approach.
Project-specific validation strategyValidation scope, system boundaries, responsibilities, testing requirements and execution sequence defined around the individual project.
Applicable regulatory and client standardsRelevant authority, client, corporate and market-specific requirements considered according to the agreed project scope.

Note: The final CQV strategy depends on the system scope, product, process, project location, regulatory pathway and site quality requirements.

Frequently asked questions

What to know before qualification begins.

CQV Frequently Asked Questions
Compliance Verified

We recommend starting CQV planning during design. User requirements, system boundaries, critical requirements, acceptance criteria and documentation expectations should be defined early so they remain traceable through qualification and validation. EU GMP Annex 15 treats qualification and validation as lifecycle activities and uses the URS as a key reference for subsequent qualification.

Commissioning demonstrates that installed systems function as intended from an engineering perspective. Qualification provides documented evidence that facilities, equipment and utilities meet approved requirements, while validation demonstrates that processes or applicable systems consistently achieve their intended results.

We determine the scope through quality-risk assessment and the project validation strategy. It may include cleanrooms, HVAC, critical utilities, process equipment, automation and other systems that can affect product quality or patient safety. EU GMP Annex 15 requires a risk-based approach when determining the scope and extent of qualification and validation.

No. We align testing, documentation and review with the system’s criticality and potential quality impact. ICH Q9(R1) states that the level of effort, formality and documentation used in quality risk management should be proportionate to the level of risk.

Yes, where the evidence is relevant, traceable and formally reviewed. Suitable testing completed earlier in the project may support qualification where justified, helping avoid unnecessary repetition while maintaining the required evidence trail.

Common causes include incomplete installation, missing vendor documents, unavailable calibration records, unresolved critical punch items, unapproved changes, protocol deviations and systems that are not ready for testing. We work to identify these readiness gaps before qualification activities begin.

Complete the readiness pathway

Move from installed systems to verified operation.

A coordinated CQV strategy helps connect design intent, installation evidence, functional testing and performance verification through one traceable pathway.